Novartis builds its blockbuster case for Entresto, beating out a cheap ACE inhibitor in a head-to-head study

Submitted by admin on November 12, 2018 - 11:49pm

Source:

Endpoints

News Tags:

Novartis

Entresto

Headline:

Novartis builds its blockbuster case for Entresto, beating out a cheap ACE inhibitor in a head-to-head study

snippet:

Novartis execs got the positive data they were looking for from their PIONEER-HF study of Entresto to back accelerating sales of the heart medication.

Search form

You are here

Novartis builds its blockbuster case for Entresto, beating out a cheap ACE inhibitor in a head-to-head study

Novartis builds its blockbuster case for Entresto, beating out a cheap ACE inhibitor in a head-to-head study